Systemic Treatment of Prostate Cancer:
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Oxford
OUP Oxford
2010
|
| Schriftenreihe: | Oxford oncology library
|
| Schlagwörter: | |
| Links: | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 |
| Beschreibung: | Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r |
| Umfang: | 1 Online-Ressource (102 pages) |
| ISBN: | 019157581X 1283348330 9780191575815 9781283348331 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043138184 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 xx o|||| 00||| eng d | ||
| 020 | |a 019157581X |c electronic bk. |9 0-19-157581-X | ||
| 020 | |a 1283348330 |9 1-283-34833-0 | ||
| 020 | |a 9780191575815 |c electronic bk. |9 978-0-19-157581-5 | ||
| 020 | |a 9781283348331 |9 978-1-283-34833-1 | ||
| 035 | |a (OCoLC)763157034 | ||
| 035 | |a (DE-599)BVBBV043138184 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.9946306 | |
| 100 | 1 | |a Horwich, Alan |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Systemic Treatment of Prostate Cancer |
| 264 | 1 | |a Oxford |b OUP Oxford |c 2010 | |
| 300 | |a 1 Online-Ressource (102 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Oxford oncology library | |
| 500 | |a Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer | ||
| 500 | |a Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r | ||
| 650 | 4 | |a Medicine | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a Prostate / Cancer / Diagnosis |2 fast | |
| 650 | 7 | |a Prostate / Cancer / Treatment |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Prostate |x Cancer |x Diagnosis | |
| 650 | 4 | |a Prostate |x Cancer |x Treatment | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028562374 | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 |l DE-1046 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 |l DE-1047 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1818981312819625984 |
|---|---|
| any_adam_object | |
| author | Horwich, Alan |
| author_facet | Horwich, Alan |
| author_role | aut |
| author_sort | Horwich, Alan |
| author_variant | a h ah |
| building | Verbundindex |
| bvnumber | BV043138184 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)763157034 (DE-599)BVBBV043138184 |
| dewey-full | 616.9946306 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9946306 |
| dewey-search | 616.9946306 |
| dewey-sort | 3616.9946306 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03004nam a2200481zc 4500</leader><controlfield tag="001">BV043138184</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">019157581X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-19-157581-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283348330</subfield><subfield code="9">1-283-34833-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780191575815</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-19-157581-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283348331</subfield><subfield code="9">978-1-283-34833-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)763157034</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043138184</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9946306</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Horwich, Alan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Systemic Treatment of Prostate Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">OUP Oxford</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (102 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Oxford oncology library</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate / Cancer / Diagnosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prostate / Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate</subfield><subfield code="x">Cancer</subfield><subfield code="x">Diagnosis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prostate</subfield><subfield code="x">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028562374</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998</subfield><subfield code="l">DE-1046</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998</subfield><subfield code="l">DE-1047</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043138184 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T17:29:20Z |
| institution | BVB |
| isbn | 019157581X 1283348330 9780191575815 9781283348331 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028562374 |
| oclc_num | 763157034 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (102 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | OUP Oxford |
| record_format | marc |
| series2 | Oxford oncology library |
| spelling | Horwich, Alan Verfasser aut Systemic Treatment of Prostate Cancer Oxford OUP Oxford 2010 1 Online-Ressource (102 pages) txt rdacontent c rdamedia cr rdacarrier Oxford oncology library Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r Medicine HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Prostate / Cancer / Diagnosis fast Prostate / Cancer / Treatment fast Medizin Prostate Cancer Diagnosis Prostate Cancer Treatment http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 Aggregator Volltext |
| spellingShingle | Horwich, Alan Systemic Treatment of Prostate Cancer Medicine HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Prostate / Cancer / Diagnosis fast Prostate / Cancer / Treatment fast Medizin Prostate Cancer Diagnosis Prostate Cancer Treatment |
| title | Systemic Treatment of Prostate Cancer |
| title_auth | Systemic Treatment of Prostate Cancer |
| title_exact_search | Systemic Treatment of Prostate Cancer |
| title_full | Systemic Treatment of Prostate Cancer |
| title_fullStr | Systemic Treatment of Prostate Cancer |
| title_full_unstemmed | Systemic Treatment of Prostate Cancer |
| title_short | Systemic Treatment of Prostate Cancer |
| title_sort | systemic treatment of prostate cancer |
| topic | Medicine HEALTH & FITNESS / Diseases / Cancer bisacsh MEDICAL / Oncology bisacsh Prostate / Cancer / Diagnosis fast Prostate / Cancer / Treatment fast Medizin Prostate Cancer Diagnosis Prostate Cancer Treatment |
| topic_facet | Medicine HEALTH & FITNESS / Diseases / Cancer MEDICAL / Oncology Prostate / Cancer / Diagnosis Prostate / Cancer / Treatment Medizin Prostate Cancer Diagnosis Prostate Cancer Treatment |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998 |
| work_keys_str_mv | AT horwichalan systemictreatmentofprostatecancer |